Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial
Journal of the American Academy of Dermatology | Jan 19, 2018
An assessment of the use of antihistamines in the management of atopic dermatitis
Journal of the American Academy of Dermatology | Jan 11, 2018
Post-diagnosis aspirin use and overall survival in patients with melanoma
Journal of the American Academy of Dermatology | Jan 11, 2018
Comparison of linoleic acid-containing water-in-oil emulsion with urea-containing water-in-oil emulsion in the treatment of atopic dermatitis: A randomized clinical trial
Clinical, Cosmetic and Investigational Dermatology | Jan 11, 2018